Latest Advances

  • Journal: The Pan African medical journal
  • Published —
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma: clinicopathological study and treatment outcome in 50 patients.
  • Journal: Transplantation and cellular therapy
  • Published —
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
  • Condition: Primary Hepatic Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
  • Journal: The Journal of international medical research
  • Treatment Used: Radiofrequency Ablation (RFA)
  • Number of Patients: 1
  • Published —
This case report describes a 63-year-old woman diagnosed with primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated with radiofrequency ablation (RFA).
  • Condition: Non Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
  • Journal: Scientific reports
  • Treatment Used: Switching Between Rituximab Biosimilars
  • Number of Patients: 83
  • Published —
This study evaluated the safety of switching between references and rituximab biosimilars in patients with non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
  • Condition: Kaposi Sarcoma (KS)-Associated Herpesvirus (KSHV)-Associated Multicentric Castleman Disease (MCD)
  • Journal: Blood advances
  • Treatment Used: High-Dose Zidovudine with Valganciclovir (AZT/VGC), Rituximab, or Rituximab with Liposomal Doxorubicin (R-Dox)
  • Number of Patients: 62
  • Published —
This study evaluated treatments for Kaposi sarcoma (KS)-associated herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) in people living with HIV (PLWH).
  • Condition: Relapsed Primary Gastric Peripheral T-Cell Lymphoma
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Total Gastrectomy followed by Add-on Chemotherapy
  • Number of Patients: 1
  • Published —
The study researched the safety and effectiveness of total gastrectomy followed by adjuvant chemotherapy for relapsed primary gastric peripheral T-cell lymphoma.
  • Condition: Diffuse Large B-Cell Lymphoma
  • Journal: Blood advances
  • Treatment Used: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  • Number of Patients: 210
  • Published —
The study researched the use of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone for treating diffuse large B-cell lymphoma.
  • Condition: Relapsed or Refractory B-Cell Malignancies
  • Journal: Lancet (London, England)
  • Treatment Used: Pirtobrutinib
  • Number of Patients: 323
  • Published —
This study evaluated the safety and effectiveness of pirtobrutinib in the treatment of patients with relapsed or refractory B-cell malignancies.
  • Condition: Extranodal NK/T Cell Lymphoma
  • Journal: Journal of medical case reports
  • Treatment Used: Atezolizumab in Combination with Intrathecal Chemotherapy
  • Number of Patients: 1
  • Published —
In this study, researchers evaluated the outcomes of atezolizumab in combination with intrathecal chemotherapy for the treatment of an isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma.
  • Condition: Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Blood advances
  • Treatment Used: Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)
  • Number of Patients: 1418
  • Published —
This study assessed progression-free survival (PFS) and overall survival (OS) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL) receiving obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP).
  • Condition: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
  • Journal: Journal of Korean medical science
  • Treatment Used: Total Body Irradiation (TBI)
  • Number of Patients: 0
  • Published —
This article summarized the use of total body irradiation (TBI) in the conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT).
  • Condition: Sézary Syndrome (SS)
  • Journal: Oncoimmunology
  • Treatment Used: Extracorporeal Photopheresis (ECP)
  • Number of Patients: 13
  • Published —
This study examined the use of extracorporeal photopheresis (ECP) in patients with Sézary syndrome (SS), a rare, leukemic cutaneous T-cell lymphoma (CTCL),
Showing 1-12 of 611